Literature DB >> 24509230

[Pulmonary malt lymphoma].

Raphaël Borie1, Martine Antoine2, Jacques Cadranel3, Marie Wislez3.   

Abstract

This review will describe the current knowledge in the pathophysiology, diagnosis, prognosis and treatment of pulmonary MALT (Mucosa Associated Lymphoid Tissue) lymphoma. Pulmonary MALT lymphomas are low-grade B cell lymphoma and are the most frequent lymphomas arising from the lung. Tumour cells arise from mucosa associated lymphoid tissue. Unlike other sites, no pathogen has been associated with pulmonary location of MALT lymphoma. However addictive translocations involving the MALT1 gene are frequently evidenced Patients are frequently asymptomatic and present with a chronic alveolar opacity. Diagnosis requires histology that may be retrieved by minimally invasive procedures during bronchial endoscopy or by CT scan guided percutaneous biopsies. Prognosis is good and treatment may vary with abstention, surgery, radiotherapy, immunotherapy or chemotherapy.

Entities:  

Keywords:  chronic alveolar opacity; clonality; oncogene; translocation

Mesh:

Year:  2014        PMID: 24509230     DOI: 10.1684/bdc.2014.1885

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  1 in total

1.  Primary pulmonary mucosa-associated lymphoid tissue lymphoma: A case report.

Authors:  Mohammad Reza Hosseini Siyanaki; Elham Askari; Sara Haseli; Nazanin Sadraei
Journal:  Radiol Case Rep       Date:  2022-10-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.